Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals.

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and antifungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our proprietary tablets, capsules and other finished dosage forms (FDFs).

First founded in 1869, it has been one of constant evolution and innovation ever since. Today we are a company with 2,700 people and operations on four continents. Moreover, we are a pharmaceutical company with a clear mission: improving lives by being central to sustainable and accessible healthcare.

Our company has a common focus that unites each of us in our mission: in all our global operations, we are committed to ensuring quality, reliability and sustainability for customers, partners, patients and the world at large.

Looking ahead, our vision is to be the leading, diversified and fully integrated partner for generic marketers.